Abstract:Macrophage mitochondrial dysfunction is associated with immunosuppression and poor prognosis of septic patients. Mitochondrial fragmentation drives mitochondrial dysfunction. Our previous study has found that S1PR2 regulates macrophage phagocytosis during sepsis, while the role of S1PR2 in immunosuppression and the mechanisms remain further studied. This study aimed to unveil the relationship between macrophage mitochondrial fragmentation and sepsis-induced immunosuppression, as well as the S1PR2-related mechanisms thereof. Peripheral blood monocytes were collected from healthy controls (n = 12), nonseptic critical controls (n = 13) and septic patients (n = 19). Peritoneal macrophages were harvested from wildtype and S1pr2-/- mice (MMRRC strain iD, 12830) after cecal ligation and puncture (CLP). Mitochondrial ultrastructure was evaluated using transmission electron microscopy. The impact of mitochondrial ultrastructure alteration on immunosuppression of monocytes-macrophages was evaluated. Compared with nonseptic and healthy controls, peripheral blood monocytes from septic patients exhibited increased S1PR2 expression, mitochondrial fragmentation, and mitochondrial dysfunction. Mitochondrial fragmentation was negatively associated with HLA-DR expression. S1PR2 expression was positively correlated with mitochondrial fragmentation and negatively correlated with HLA-DR expression. In mice subjected to CLP, S1PR2 depletion ameliorated macrophage mitochondrial fragmentation and dysfunction, boosted immunity, and improved survival. Mechanistically, in response to sepsis, S1PR2 activates ROCK I to induce Drp1 phosphorylation, resulting in Drp1-dependent mitochondrial fragmentation of macrophages. Drp1 inhibition by Mdivi-1 mitigated S1PR2-induced macrophage immunosuppression and improved the prognosis of mice following CLP. In conclusion, S1PR2-induced mitochondrial fragmentation is a crucial factor mediating septic immunosuppression, highlighting its potential as a promising therapeutic target in sepsis.

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mechanism and role of mitophagy in the development of severe infection

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

The Role of Autophagy in Sepsis: Protection and Injury to Organs

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

The role of mitophagy in pulmonary sepsis

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

[Research of Progress of Mitochondria in the Pathogenesis of Sepsis].

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

[Research progress of mitochondrial dysfunction in the pathogenesis of septic acute kidney injury].

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

Mitochondria-Derived Damage-Associated Molecular Patterns In Sepsis: From Bench To Bedside

Sepsis induced myocardial mitochondrial oxidative damage in the elderly

Macrophage S1PR2 Drives Sepsis-induced Immunosuppression by Exacerbating Mitochondrial Fragmentation

Mitochondrial dysfunction and resuscitation in sepsis

Disturbance of mitochondrial dynamics and mitophagy in sepsis-induced acute kidney injury

Energy metabolism: from physiological changes to targets in sepsis-induced cardiomyopathy

Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy

Autophagy: A Potential Therapeutic Target For Reversing Sepsis-Induced Immunosuppression